NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- MemeCore, the first Layer 1 blockchain built for Meme 2.0, successfully concluded…
LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which Euro NCAP gave to the ATTO 3’s Assisted…
Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 24, 2025…
WUHU, China, Sept. 24, 2025 /PRNewswire/ -- From October 17–21, 2025, the Chery International User Summit, themed "CO-CREATE•CO-DEFINE", will debut as…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…
BANGALORE, India, Sept. 16, 2025 /PRNewswire/ -- izmomicro (www.izmomicro.com), a division of izmo Ltd., today announced a major breakthrough in high-performance…
SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials, Kerry's LC40® is the first probiotic…